FierceBiotech November 25, 2025

<a href="https://www.fiercebiotech.com/medtech/roche-inks-200m-licensing-pact-freenomes-cancer-screening-blood-tests" hreflang="en">Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests</a>

Roche will make a new $75 million equity investment in Freenome, toward the goal of developing blood testing kits for markets outside the U.S.